Netherlands: For the fourth year running, new HIV diagnoses are climbing — 500 people learned they carried the virus in 2025, up from 441 in 2020 — and the sharp rise among young men is exposing gaps in prevention knowledge and access to the PrEP pill, Stichting hiv monitoring reported on Thursday.
The figures, published Thursday by Stichting hiv monitoring (SHM), mark a clear break with a decade of progress. New infections fell steeply from 2010 onward, and prevention tools — condoms, pre-exposure prophylaxis (PrEP), rapid testing — had made it plausible to imagine HIV disappearing as a sexually transmitted infection in the Netherlands, de Volkskrant reported. That trajectory has now reversed.
The rise is concentrated among people born in or after 1990, and especially among young men who have sex with men. Internist-infectiologist Marc van der Valk, who heads the HIV outpatient clinic at Amsterdam UMC and serves on SHM’s board, tied the increase directly to fading prevention awareness.
Marc van der Valk said that knowledge about HIV prevention is really declining, not only in that group, but also among doctors and care professionals, adding that alongside condoms, which of course work very well, we also have the PrEP pill.
In Plain English: The Clinical Takeaway
- HIV is a virus that gradually breaks down the immune system; AIDS is its advanced stage. With modern medication, AIDS has become rare in the Netherlands.
- PrEP (pre-exposure prophylaxis) is a pill that prevents HIV infection during sex. People who take it as prescribed cannot acquire HIV sexually.
- People with HIV who take their medication consistently cannot transmit the virus at all — a principle known as treatment as prevention.
A trend break four years in the making
The reversal was not visible immediately. SHM records diagnoses only once people consent to inclusion in its database, so figures from earlier years are filled in retrospectively, NRC reported. Only with that backfill did 2022 emerge as the first year in which diagnoses rose compared with the year before — and they have climbed annually since.

The scale of the shift is modest in absolute terms but epidemiologically significant. In 2025, 500 people received a diagnosis, against 425 four years earlier, de Volkskrant reported. Model calculations — which estimate infections that have occurred but not yet been diagnosed — suggest the number of diagnoses will keep rising in the coming years unless prevention improves.
Estimated infections tell the same story. They have stopped falling since 2020 and rose over the last two years, NRC reported. Because HIV typically causes no symptoms for an average of about seven years after infection, an estimated 1,650 people in the Netherlands did not know at the end of last year that they carried the virus, according to de Volkskrant.
| Measure | Figure | Source |
|---|---|---|
| HIV diagnoses, 2020 | 441 | NRC / Trouw |
| HIV diagnoses, 2025 | 500 | NRC / Trouw |
| People living with diagnosed HIV, end 2025 | 26,225 | Het Parool |
| AIDS deaths, 2025 | 19 | Het Parool |
Young men born after 1990 drive the rise
The demographic pattern is the sharpest signal in the data. Among men who have sex with men and were diagnosed between 2023 and 2025, 47 percent were born in or after 1990, compared with 29 percent of other men and 30 percent of women, Het Parool reported. Ten years ago, people born in or after 1990 accounted for just 16 percent of diagnoses, de Volkskrant reported.
Testing behaviour within this group points to recent infections. About 70 percent of these young men had previously tested negative for HIV, and for 35 percent that negative test came within the year before their diagnosis, Het Parool reported. Van der Valk said that pattern indicates a recent infection — and, on the positive side, that people are testing regularly, which creates opportunities for clinicians to discuss prevention when delivering a negative result.
/s3/static.nrc.nl/wp-content/uploads/2026/11/18192100/191126VER_2038680606_.jpg)
“We are now seeing exactly happen what we have been warning about for several years,” Van der Valk said, according to NRC. “That is worrying, because we have all the means to prevent HIV transmission.”
PrEP works but access remains difficult
Van der Valk was explicit that the pill itself is not failing. A growing share of people diagnosed with HIV had previously used PrEP, he noted, according to Het Parool — but that reflects inconsistent use or people stopping the medication, not a lack of efficacy. Users, he said, need better guidance and monitoring when they discontinue.
Access is the bigger obstacle. PrEP has been approved since 2018 and is available through the sexual health centres of the municipal health services (GGD) and through GPs, Trouw reported. But GGD services, though free and anonymous, carry long waiting lists in large cities, and some GPs still assume PrEP care belongs at the GGD rather than in general practice.
Cost adds another barrier. The pill runs between 12 and 30 euros per month depending on where it is bought — a sum that weighs heavily on young people, sex workers and other vulnerable groups, Sjoerd van Elsen, policy officer at Soa Aids Nederland, told Trouw.
In research cited by NRC, 18 percent of men who have sex with men who qualify for PrEP do not take it partly because of the cost, and 27 percent find it complicated to obtain.
Sjoerd van Elsen said that with PrEP in the basic insurance package, you remove that barrier and you come out relatively cheap, noting that treating a person with HIV can quickly cost hundreds of thousands of euros over a lifetime, particularly when infection occurs early in life.
Soa Aids Netherlands wants PrEP added to the standard insurance package; it currently falls outside it, though PrEP care has been available to everyone for two years, de Volkskrant reported.
From broadcast studios to school curricula
The rise has reached beyond the clinic. Presenter Jurre Geluk, known for the Dutch sex-education programme Spuiten en slikken, told the ANP he views the figures with concern and made a two-part YouTube series, PrEPtalk, partly in response to the rising diagnoses, De Telegraaf reported.
Jurre Geluk said that the link still needs to be made to what it’s worth to protect yourself, because it only has to go wrong once, asking what that is worth compared with making the effort at the GP.
Soa Aids Netherlands is pushing education measures aimed at exactly the age group now absorbing the rise: making PrEP a topic in secondary-school sexuality curricula and tailoring materials to the language and lives of specific target groups, Trouw reported. Van der Valk, per de Volkskrant, called for working with the affected communities and connecting information directly to routes for testing, PrEP and care.
When PrEP is not suitable and when to seek medical advice
PrEP is a prescription medication and is not appropriate for everyone. It requires a confirmed negative HIV test before starting and regular follow-up — typically checks for HIV and other sexually transmitted infections every six months, as the sources describe for GP-delivered PrEP care. Anyone who believes they may have been exposed to HIV, or who has symptoms that could indicate acute infection, should seek testing promptly through a GP or a GGD sexual health centre.
People already prescribed PrEP who stop taking it should, per Van der Valk’s remarks to Het Parool, remain under medical monitoring rather than discontinue without guidance. This article reports on the Dutch healthcare system as described in the sources; readers elsewhere should consult their national health authority for locally applicable guidance.
What the numbers say about the road ahead
There are genuine positives in the data. Most of the 26,225 people living with HIV in the Netherlands at the end of 2025 — 22,602 — have successfully suppressed the virus through treatment, Het Parool reported. AIDS deaths have held steady at a low level since 2015, with 19 in 2025, and early diagnosis itself is a favourable development, Van der Valk said in a press statement carried by Het Parool.
The open question is prevention. Without targeted action among young people, SHM warns, the number of diagnoses will keep climbing. The organisation’s message, as Van der Valk put it to NRC, is blunt: “We have all the means to prevent HIV transmission.”
Amsterdam UMC, where van der Valk heads the HIV outpatient clinic, was formed in 2018 through the merger of the city’s two university medical centers, the Academic Medical Center and the VU University Medical Center, with a full legal merger completed on 1 January 2024. In 2025, Newsweek ranked it the best hospital in the Netherlands and the 31st best in the world.
Its research tradition in the city reaches back to Dr. Nicolaes Tulp, the University of Amsterdam’s first anatomist, immortalised in Rembrandt’s The Anatomy Lesson of Dr. Nicolaes Tulp. Between 2015 and 2018, the institution contributed to more than 22,000 scientific publications, the most of any Dutch university medical center and second highest in Europe.
References
- Stichting hiv monitoring (SHM), 2025 HIV Monitor figures, as reported by Het Parool and NRC
- Trouw — reporting on PrEP access, costs and Soa Aids Netherlands policy positions
- de Volkskrant — four-year trend, model calculations and undiagnosed infection estimates
- De Telegraaf — Jurre Geluk reaction via ANP
- RTV Utrecht — background on HIV and AIDS
Disclaimer: This article is journalistic reporting and does not constitute medical advice. Consult a qualified healthcare provider for personalised guidance on HIV testing, prevention or treatment.